Navigation Links
Joint Replacement Soars as Number of Docs Falls

Low reimbursement rates turning many young doctors off the specialty, researcher says

THURSDAY, Feb. 26 (HealthDay News) -- More people are lining up for hip and knee replacements, just as the number of surgeons who do them is falling, two new studies reveal.

Both reports were presented Wednesday at the American Academy of Orthopaedic Surgeons annual meeting, in Las Vegas.

"In 2016, nearly 200,000 patients who require hip replacement and 750,000 patients who require knee replacement will not be able to have their surgery performed, because there will not be enough orthopedic surgeons available to do the procedure," said Dr. Thomas K. Fehring, lead researcher of the first study and an orthopedic surgeon with OrthoCarolina in Charlotte, N.C.

For the study, Fehring's team looked at the retirement age of doctors performing hip and knee replacements and the number of new doctors entering the field. Using this data, the researchers calculated the number of doctors who will be available to perform these procedures in 2016.

They found that by 2016, there will be significantly fewer doctors available to replace those who retire. By 2016, 46 percent of patients needing hip replacements will not get them, and 72 percent of those needing knee replacements will have to wait.

"I understood that there were not as many young surgeons going into the arthroplasty field as were retiring from the arthroplasty field, but it shocked me that, if the trends continue, nearly a million patients who need hip and knee replacements in 2016 will not have access to this life-changing procedure," Fehring said.

Low insurance reimbursements for these procedures appear to be keeping new doctors from choosing this specialty, Fehring said. Reimbursement for joint replacement has decreased 60 percent in inflation adjusted dollars since 1990.

"These economic realities are not lost on our residents in training when selecting a career," Fehring said. "Unless things change, this will lead to excessive waiting times for our senior citizens requiring joint replacement. Wait times of one to two years may ensue, which will be unacceptable to the general public," he said.

In the second study, Steven M. Kurtz, vice president of Exponent Inc., an engineering and scientific consulting firm based in Philadelphia, and his colleagues found the dramatic increase in the demand for joint replacements is largely driven by younger patients.

The researchers found that by 2011, more than 50 percent of patients needing hip replacement will be under 65, and that by 2016, more than half of those needing knee replacement will be also be under 65.

Many patients needing knee replacement are between 45 and 54. In 2006, 59,077 people in this age group had knee replacements, but by 2030, that number will increase 17 times to almost 1 million, Kurtz's team found.

This trend is driven by the success of these procedures as well as by people being more active and also obesity, which can trigger arthritis at an earlier age, Kurtz said. In addition, as the population ages, there will be a need for joint replacement in many more older people, he noted. "You either have a huge increase or a gigantic increase," he said.

Dr. Craig J. Della Valle, an associate professor of orthopedic surgery at Rush University Medical Center, in Chicago, said the findings of both studies are "worrisome."

"This mirrors what I am seeing in my own practice," Della Valle said. "The number of patients having these procedures is really increasing rapidly. It seems we are seeing more younger patients. Unfortunately, we are also seeing fewer surgeons who are choosing this as a specialty."

Dr. Hari Parvataneni, an assistant professor of orthopedic surgery at the University of Miami School of Medicine, said that the average joint replacement lasts 20 years, so as more younger people are having joint replacement surgery, the need for surgery to replace replacements will also grow.

"As the burden of joint replacements increase at a phenomenal rate, the burden of revision procedures increases," Parvataneni said. "Some of these revision procedures will require two to three times the cost of the primary implant, two to three times the clinical time of surgeons, but they only pay 20 percent more," he said. So, there are even fewer surgeons doing complex revisions, he said.

Parvataneni thinks that despite the low reimbursements issue, more surgeons should choose joint replacement. "It's hard to beat this specialty -- you change people's lives, and they are very happy for a long time," he said.

More information

For more on joint replacement, visit the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases.

SOURCES: Thomas K. Fehring, M.D., OrthoCarolina, Charlotte, N.C.; Steven M. Kurtz, Ph.D., vice president, Exponent Inc., Philadelphia; Craig J. Della Valle, M.D., associate professor, orthopedic surgery, Rush University Medical Center, Chicago; Hari Parvataneni, M.D., assistant professor, orthopedic surgery, University of Miami School of Medicine; Feb. 25, 2009, presentations, American Academy of Orthopaedic Surgeons annual meeting, Las Vegas

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. QSAI & SGS-CSTC to Begin Joint Food Analysis Services in China
2. The Most Breaking News in the Joint
3. Video: Majority of Americans Over 45 Experience Joint Pain and Believe it will Affect Their Future Quality of Life
4. Northwest Kidney Centers Hospital Services Department Awarded Joint Commission Certification
5. More Fast-Food Joints in Neighborhoods Mean More Strokes
6. Nucletron and Advanced Radiation Therapy (ART) Jointly Announce a Global, Strategic Partnership to Offer AccuBoost(R) for Image-Guided Breast Irradiation
7. Joint Commission, National Quality Forum Now Accepting Applicants for the 2009 John M. Eisenberg Patient Safety and Quality Awards
8. U.S. Preventive Medicine(R), The Mount Sinai Medical Center Sign Affiliation Agreement to Jointly Deliver Preventive Medicine Services
9. A Checklist for Joint Replacement Surgery
10. Sierra Tucson Achieves Hospital Accreditation, Now Holds Dual Accreditation by the Joint Commission
11. Brigham and Associates and Insurance Recovery Group Launch Impairment Resources, a Joint Venture to Address Impairment Ratings
Post Your Comments:
Related Image:
Joint Replacement Soars as Number of Docs Falls
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... ... December 01, 2015 , ... For the ... is why Hollister Incorporated has launched the VaPro Plus Pocket™ touch free hydrophilic ... the VaPro touch free catheter portfolio,” said Michael Gresavage, Vice President North America. ...
(Date:12/1/2015)... ... December 01, 2015 , ... Next IT Healthcare, the leader ... in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the ... finalist in the category of Digital Solutions for its innovative, industry-leading product, Alme ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , December 1, 2015 Russia ... phase III clinical trials. 70% of new drugs registered in ... trials in Russia . --> Russia has ... trials. 70% of new drugs registered in Europe ... . --> Russia has always been ...
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology: